Coeptis Therapeutics Holdings, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| DeSilva Tara | — | Purchase | 1,800 | $0.58 | $1,044 | 32,266 | Jan 12, 2024 |
| Cogley Brian | Chief Financial Officer | Purchase | 5,000 | $0.67 | $3,350 | 30,000 | Jan 10, 2024 |
| Mehalick David | CEO and President | Purchase | 5,050 | $0.69 | $3,484 | 2,762,611 | Jan 8, 2024 |
| Yerace Daniel Alexander | VP of Operations | Purchase | 10,850 | $0.69 | $7,486 | 1,071,455 | Jan 5, 2024 |
| Salkind Gene | — | Purchase | 11,600 | $0.69 | $8,004 | 284,056 | Jan 5, 2024 |
| Cochran Christopher P. | — | Purchase | 7,000 | $0.77 | $5,390 | 37,000 | Jan 5, 2024 |
| Mehalick David | CEO and President | Gift | 700,000 | — | — | 2,757,561 | Dec 7, 2023 |
| Salkind Gene | — | Purchase | 28,638 | $0.91 | $26,061 | 28,638 | Aug 29, 2023 |
| Calise Chris | — | Purchase | 2,582 | $0.94 | $2,427 | 1,464,897 | Aug 23, 2023 |
| Harraden Circle Investors GP, LP | — | Sale | 85,305 | $10.11 | $862,434 | 429,131 | May 4, 2022 |
| GLAZER CAPITAL, LLC | — | Sale | 50,000 | $9.85 | $492,500 | 1,016,500 | May 26, 2021 |
| Calise Chris | Chief Financial Officer | Other | 281,250 | — | — | 1,875,000 | Dec 14, 2020 |
| Striar Robert | Chief Executive Officer | Other | 281,250 | — | — | 1,875,000 | Dec 14, 2020 |
| Bull Horn Holdings Sponsor LLC | — | Other | 281,250 | — | — | 1,875,000 | Dec 14, 2020 |